Growth hormone therapy for adult growth hormone deficiency

International Journal of Clinical Practice

Volumn 52, Issue 2, 1998, Pages 108-111

  Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; INSULIN; LIPID;

BODY COMPOSITION; EXERCISE; GROWTH HORMONE DEFICIENCY; HEALTH CARE ORGANIZATION; HORMONAL THERAPY; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; OSTEOPENIA; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY;

ADULT; BONE DENSITY; CHILD; GROWTH HORMONE; HUMANS; LIPIDS; PATIENT SELECTION; QUALITY OF LIFE;

EID: 0031932867     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Jorgensen JOL, Pedersen SA, Thuesen L et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1: 1221-1225.
2. Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
3. DeBoer H, Blok GJ, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995; 16: 63-86.
4. Rosén T, Johannsson G, Hallgren P et al. Beneficial effects of 12 months replacement with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metabol 1994; 1: 55-66.
5. Hansen TB, Vahl N, Jorgensen JOL et al. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomised, placebo-controlled study. Clin Endocrinol 1995; 43: 689-696.
6. Cuneo RC, Salomon F, Watts GF et al. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 1993; 42: 1519-1523.
7. Eden S, Wiklund O, Oscarsson J et al. Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993; 13: 296-301.
8. DeBoer H, Blok GJ, Voerman HJ et al. Serum lipid levels in growth hormone deficient men. Metabolism 1994; 43: 199-203.
9. Nass R, Huber RM, Klauss V et al. Effect of growth hormone replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metabol 1995; 80: 552-557.
10. O'Halloran DJ, Tsatsoulis A, Whitehouse RW et al. Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency. J Clin Endocrinol Metabol 1993; 76: 1344-1348.
11. Holmes SJ, Economou G, Whitehouse RW et al. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metabol 1994; 78: 669-674.
12. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K et al. Increased fracture rate in growth hormone deficient adults. Proc 77th Ann Meeting Endocrine Society 1995; P2 (Abstract): 251.
13. Holmes SJ, Whitehouse RW, Swindell R et al. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol 1995; 42: 627-633.
14. Johannsson G, Rosen T, Bosaeus I et al. Long-term growth hormone treatment increases bone mineral content and density in patients with adult-onset growth hormone deficiency. J Clin Endocrinol Metabol 1996; 81: 2865-2873.
15. Björk S, Jönsson B, Westphal O, Levin JE. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand 1989; 356(suppl): 55-59.
16. McKenna SP, Doward LC. Quality of life assessment of adults with growth hormone deficiency: implications for drug therapy. Pharmaco-Economics 1994; 6: 434-441.
17. Rosen T, Wiren L, Wilhelmsen L et al. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 1994; 40: 111-116.
18. Johansson JO, Larson G, Andersson M et al. Treatment of growth hormone deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995; 61: 57-66.
19. Mardh G, Lundin K, Borg G et al. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinol Metabol 1994; 1(suppl A): 43-49.
20. Rosen T, Bengtsson B. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
21. Bulow B, Hagmar L, Mikoczy Z et al. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75-81.
22. Markussis V, Beshyah SA, Fisher C et al. Detection of premature atherosclerosis by high resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-1192.
23. Lehmann ED, Hopkins KD, Weissberger AJ et al. Aortic distensibility in growth hormone deficient adults. Lancet 1993; 341: 309.
24. Thorner MO et al. The diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab 1995; 80: 3097-3098.
25. Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994; 41: 511-516.
26. Johanssen JO, Landin K, Tengborn L et al. High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arterioscler Thromb 1994; 14: 434-437.
27. Holmes SJ, Shalet SM. Characteristics of adults who wish to enter a trial of growth hormone replacement. Clin Endocrinol 1995; 42: 613-618.
28. Holmes SJ, Shalet SM. Factors influencing the desire for long term growth hormone replacement in adults. Clin Endocrinol 1995; 43: 151-157.